Skip to main content
. 2017 Oct 12;4(4):554–557. doi: 10.1001/jamaoncol.2017.3159

Figure 2. Progression-Free Survival Stratified by HSD3B1 Genotype.

Figure 2.

Sufficient data were available to determine time to progression for 81 patients. Forty-one patients were HSD3B1 homozygous wild type; 29, heterozygous; and 11 homozygous. Median time to disease progression increased with the number of variant HSD3B1 alleles inherited.